The 2026 European Neurofibromatosis Conference (Event EMT-26-09420) was classified as compliant by Ethical MedTech Europe.
Further information can be found here: https://cvs.solutions.iqvia.com/event/detail/EMT-26-09420.
Official Italian Agency for AIFA Procedure: Any Italian pharmaceutical company supporting or participating in a congress abroad is subject to authorization by AIFA (Italian Medicines Agency), according to Italian Government Decree (Decreto Legislativo 219/06 – art. 124).
The request for authorization must be submitted at least 60 days before the start date of the event. The appointed agency to collect all applications from pharmaceutical companies and file them with AIFA is:
AIM Group International - AIM Education S.r.l. -Viale Enrico Forlanini, 23 – 20134 Milan, Italy Tel. +39 02 56601.1 E-mail: aifa@aimgroup.eu.
The 2026 European Neurofibromatosis Conference in Vienna (12–14 November) is now fully booked. Explore advances in NF1, Schwannomatosis, and patient-centred research at Hyatt Regency Vienna (previously Andaz Vienna Am Belvedere).